The Effect of Dexmedetomidine on the Microcirculation in Patients With Severe Sepsis and Septic Shock
Phase of Trial: Phase IV
Latest Information Update: 06 Mar 2019
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam; Propofol
- Indications Sepsis; Septic shock
- Focus Pharmacodynamics
- 28 Feb 2019 Status changed from recruiting to discontinued.
- 31 Aug 2018 Biomarkers information updated
- 20 Dec 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.